Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 8/20 | 0.81 |
| ▸ | DRD3 | P35462 | 5/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HTR1A | P08908 | 3/20 | 0.54 |
| ▸ | HTR2A | P28223 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9199135 | 0.89 | DRD2 (1.00) | DRD2DRD3ALDH1A1HTR1AHTR2A | |
| SCHEMBL9195887 | 0.88 | DRD2 (0.64) | DRD2DRD3ALDH1A1 | |
| SCHEMBL8172030 | 0.83 | DRD2 (0.80) | DRD2DRD3ALDH1A1POLB | |
| SCHEMBL8172032 | 0.83 | DRD2 (0.80) | DRD2DRD3ALDH1A1POLB | |
| SCHEMBL13648727 | 0.82 | DRD2 (0.62) | DRD2DRD3ALDH1A1HTR1AHTR2A | |
| SCHEMBL9200670 | 0.82 | DRD2 (0.85) | DRD2DRD3ALDH1A1HTR1AHTR2A | |
| SCHEMBL9196530 | 0.82 | DRD2 (0.85) | DRD2DRD3HTR1AHTR2A | |
| SCHEMBL61850 | 0.81 | DRD2 (0.66) | DRD2DRD3CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9841829 | 0.80 | DRD2 (0.81) | DRD2DRD3HTR1AHTR2A | |
| SCHEMBL9197525 | 0.80 | DRD2 (0.81) | DRD2DRD3HTR1AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0431580-B1 | Substituted cyclohexanols as central nervous system agents | WARNER LAMBERT CO (US) | 1995-03-08 | — | — | EP | claimed |
| EP-0431580-A2 | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | claimed |
| EP-0431580-B1 | Substituted cyclohexanols as central nervous system agents | WARNER LAMBERT CO (US) | 1995-03-08 | — | — | EP | disclosed |
| US-5047406-A | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT CO. (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0431580-A2 | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | disclosed |